Literature DB >> 1090534

Interactions between Mycoplasma pneumoniae and guinea pig complement.

W Bredt, D Bitter-Suermann.   

Abstract

The "toxic" effect of guinea pig serum (GPS) on Mycoplasma pneumoniae cells was tested under various conditions, using rounding and killing of the cells as test systems. Both activities could be inhibited by heat inactivation (56 C, 30 min). Killing required both Ca2+ and Mg2+, rounding only Mg2+. Both activities were temperature dependent and no rounding or killing occurred at 4C. Incomplete complement sequences with natural of artificial defects in C1, C4, or C6 resulted in lost or reduced killing. The rounding activity was only slightly affected. Anti-C3 antiserum blocked both phenomena; incubation of GPS with 10 mg of inulin per ml reduced the rounding activity, and the same treatment of GPS deficient in C4 inhibited rounding totally. Properdin factor D was shown to be necessary for rounding by GPS, with defects in either C1 or C4. By immune adherence bound C3b could be demonstrated on M. pneumoniae cells after GPS treatment, no antibodies against M. pneumoniae could be found in GPS by immune fluorescence. The results give evidence for complement being the toxic factor in GPS. Efficient killing requires the intact complement sequence. Furthermore, M. pneumoniae cells are able to activate the alternate pathway of complement. Activation of this pathway results in rounding of the cells, which are partly able to recover after this reaction. Biological consequences for the mycoplasmas are death or damage and possibly opsonization, even in the absence of specific antibodies. The host, too, is possibly affected by products of the reaction. The interaction of M. pneumoniae and complement could be involved in the early stages of the development of M. pneumoniae disease.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1090534      PMCID: PMC415093          DOI: 10.1128/iai.11.3.497-504.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Properdin system and immunity. II. Interaction of the properdin system with polysaccharides.

Authors:  L PILLEMER; M D SCHOENBERG; L BLUM; L WURZ
Journal:  Science       Date:  1955-09-23       Impact factor: 47.728

2.  Heat labile opsonins to Pneumococcus. 3. The participation of immunoglobulin and of the alternate pathway of C3 activation.

Authors:  J A Winkelstein; H S Shin; W B Wood
Journal:  J Immunol       Date:  1972-06       Impact factor: 5.422

3.  Activation of human complement by human lymphoid cells sensitized with histocompatibility alloantisera.

Authors:  S Ferrone; N R Cooper; M A Pellegrino; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

4.  The role of late complement components and the alternate complement pathway in experimental cryptococcosis.

Authors:  R D Diamond; J E May; M Kane; M M Frank; J E Bennett
Journal:  Proc Soc Exp Biol Med       Date:  1973-10-01

5.  Analysis of bypass activation of C3 by endotoxic LPS and loss of this potency.

Authors:  M P Dierich; D Bitter-Suermann; W König; U Hadding; C Galanos; E T Rietschel
Journal:  Immunology       Date:  1973-04       Impact factor: 7.397

6.  The reaction of zymosan with the properdin system: isolation of purified factor D from guinea pig serum and study of its reaction characteristics.

Authors:  V Brade; A Nicholson; G D Lee; M M Mayer
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

7.  Complement dependent killing of Mycoplasma pneumoniae by antibody: kinetics of the reaction.

Authors:  J L Gale; G E Kenny
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

8.  Tissue cultures and mycoplasmas.

Authors:  L Hayflick
Journal:  Tex Rep Biol Med       Date:  1965-06

9.  A color test for the measurement of antibody to the non-acid-forming human Mycoplasma species.

Authors:  R H Purcell; D Taylor-Robinson; D C Wong; R M Chanock
Journal:  Am J Epidemiol       Date:  1966-07       Impact factor: 4.897

10.  Factors influencing growth inhibition of Mycoplasma pneumoniae by immune sera.

Authors:  G W Fernald; W A Clyde; F W Denny
Journal:  Proc Soc Exp Biol Med       Date:  1967-10
View more
  15 in total

Review 1.  Immunity to mycoplasma infections of the respiratory tract: a review.

Authors:  G Taylor
Journal:  J R Soc Med       Date:  1979-07       Impact factor: 5.344

2.  Interaction of Mycoplasma pneumoniae with alveolar macrophages: viability of adherent and ingested mycoplasmas.

Authors:  P Erb; W Bredt
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

3.  Complement components (C1, C2, C3, C4) in bronchial secretions after intranasal infection of guinea pigs with Mycoplasma pneumoniae: dissociation of unspecific and specific defense mechanisms.

Authors:  M Loos; H Brunner
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

4.  Motility of Mycoplasma pneumoniae.

Authors:  U Radestock; W Bredt
Journal:  J Bacteriol       Date:  1977-03       Impact factor: 3.490

5.  Phagocytosis by macrophages of mycoplasma pneumoniae after opsonization by complement.

Authors:  W Bredt
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

6.  Antibodies to Acholeplasma laidlawii membrane lipids in normal guinea pig serum.

Authors:  I Dörner; H Brunner; H G Schiefer; M Loos; H J Wellensiek
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

Review 7.  Response of guinea pigs and hamsters to experimental infection with Mycoplasma pneumoniae.

Authors:  H Brunner; U Brück; D Lambert; D Sziegoleit; H Schiefer
Journal:  Infection       Date:  1976       Impact factor: 3.553

8.  Release of Mycoplasma pneumoniae substances after phagocytosis by guinea pig alveolar macrophages.

Authors:  M Kist; E Jacobs; W Bredt
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

9.  Interactions between mycoplasma pneumoniae and the first components of complement.

Authors:  W Bredt; B Wellek; H Brunner; M Loos
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

Review 10.  Pathogenicity factors of mycoplasmas.

Authors:  W Bredt
Journal:  Infection       Date:  1976       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.